Toxocara and Toxocariasis
- 1st Edition, Volume 109 - April 30, 2020
- Latest edition
- Editor: Dwight D. Bowman
- Language: English
Toxocara and Toxocariasis, Volume 109 in the Advances in Parasitology series, includes medical studies of parasites of major influence, along with reviews of more tradition… Read more
Description
Description
Toxocara and Toxocariasis, Volume 109 in the Advances in Parasitology series, includes medical studies of parasites of major influence, along with reviews of more traditional areas, such as zoology, taxonomy and life history, all topics which help to shape current thinking and applications. This latest release includes chapters on organism and the recognition of the disease, dogs (and cats) disease, diagnosis, prevalence of infection, and treatment, and more.
Key features
Key features
- Informs and updates on all the latest developments in the field of parasitology
- Contains contributions from leading authorities and industry experts
- Features reviews of more traditional areas, such as zoology, taxonomy and life history, which help to shape current thinking and applications
Readership
Readership
PhD students, professors, scientists, health workers, government officers, and policy makers at various levels
Table of contents
Table of contents
PART I - The organism and the recognition of the disease
1. Toxocara: Protecting pets and improving the lives of people
2. History of Toxocara and the associated larva migrans
3. The anatomy of the third-stage larva of Toxocara canis and Toxocara cati
4. Visceral larval migrans of Toxocara canis and Toxocara cati in non-canid and non-felid hosts
5. Toxocara “omics” and the promises it holds for medicine and veterinary medicine
PART II - The effects of infection, host response to infection, diagnosis, and treatment of people
6. Toxocariasis and the clinical spectrum
7. Serodiagnostic methods for diagnosing larval toxocariasis
8. Clinical pathology of larval toxocariasis
9. Imaging of toxocariasis
10. Toxocara-induced neural larva migrans (neurotoxocarosis) in rodent model hosts
11. Neurotoxocariasis
12. Pathogenesis of cerebral toxocariasis and neurodegenerative diseases
13. Neurocognitive and neuropsychiatric effects of toxocariasis
PART III – Epidemiology
14. Global and regional seroprevalence estimates for human toxocariasis: A call for action
15. Toxocara seroprevalence in Canada—Climate, environment and culture
16. Toxocara seroprevalence in the USA and its impact for individuals and society
17. Toxocara: Seroprevalence in Mexico
18. Seroprevalence Brazil
19. Seroprevalence of human toxocarosis in Europe: A review and meta-analysis
20. Seroprevalence and incidence of human toxocarosis in Russia
21. Current epidemic situation of human toxocariasis in China
22. Seroprevalence of Toxocara spp. infection in Southeast Asia and Taiwan
23. Sources and seroprevalence of toxocariasis in Turkey
24. Seroprevalence of Toxocara spp. antibodies in humans in Africa: A review
25. Seroepidemiology of human toxocariasis in North Africa
PART IV - Dogs (and cats) disease, diagnosis, prevalence of infection, and treatment
26. Pathology of larvae and adults in dogs and cats
27. Antigen detection: Insights into Toxocara and other ascarid infections in dogs and cats
28. Global prevalence of Toxocara infection in dogs
29. Sources of environmental contamination with Toxocara spp.: An omnipresent parasite
30. Global prevalence of Toxocara infection in cats
31. Toxocara spp. in dogs and cats in Canada
32. Toxocara canis and Toxocara cati in domestic dogs and cats in the United States, Mexico, Central America and the Caribbean: A review
33. Toxocara prevalence in dogs and cats in Brazil
34. Prevalence of Toxocara spp. in dogs and cats in South America (excluding Brazil)
35. Prevalence of patent Toxocara spp. infections in dogs and cats in Europe from 1994 to 2019
36. Toxocara prevalence in dogs, cats and the environment in Russia
37. Canine Toxocariosis: Its prevalence, incidence and occurrence in the Indian subcontinent
38. Epidemiology of Toxocara spp. in dogs and cats in mainland China, 2000–2019
39. Prevalence of Toxocara in dogs and cats in Africa
40. Toxocara canis in Australia
41. Toxocariasis: A neglected infection for the Anthropocene epoch
1. Toxocara: Protecting pets and improving the lives of people
2. History of Toxocara and the associated larva migrans
3. The anatomy of the third-stage larva of Toxocara canis and Toxocara cati
4. Visceral larval migrans of Toxocara canis and Toxocara cati in non-canid and non-felid hosts
5. Toxocara “omics” and the promises it holds for medicine and veterinary medicine
PART II - The effects of infection, host response to infection, diagnosis, and treatment of people
6. Toxocariasis and the clinical spectrum
7. Serodiagnostic methods for diagnosing larval toxocariasis
8. Clinical pathology of larval toxocariasis
9. Imaging of toxocariasis
10. Toxocara-induced neural larva migrans (neurotoxocarosis) in rodent model hosts
11. Neurotoxocariasis
12. Pathogenesis of cerebral toxocariasis and neurodegenerative diseases
13. Neurocognitive and neuropsychiatric effects of toxocariasis
PART III – Epidemiology
14. Global and regional seroprevalence estimates for human toxocariasis: A call for action
15. Toxocara seroprevalence in Canada—Climate, environment and culture
16. Toxocara seroprevalence in the USA and its impact for individuals and society
17. Toxocara: Seroprevalence in Mexico
18. Seroprevalence Brazil
19. Seroprevalence of human toxocarosis in Europe: A review and meta-analysis
20. Seroprevalence and incidence of human toxocarosis in Russia
21. Current epidemic situation of human toxocariasis in China
22. Seroprevalence of Toxocara spp. infection in Southeast Asia and Taiwan
23. Sources and seroprevalence of toxocariasis in Turkey
24. Seroprevalence of Toxocara spp. antibodies in humans in Africa: A review
25. Seroepidemiology of human toxocariasis in North Africa
PART IV - Dogs (and cats) disease, diagnosis, prevalence of infection, and treatment
26. Pathology of larvae and adults in dogs and cats
27. Antigen detection: Insights into Toxocara and other ascarid infections in dogs and cats
28. Global prevalence of Toxocara infection in dogs
29. Sources of environmental contamination with Toxocara spp.: An omnipresent parasite
30. Global prevalence of Toxocara infection in cats
31. Toxocara spp. in dogs and cats in Canada
32. Toxocara canis and Toxocara cati in domestic dogs and cats in the United States, Mexico, Central America and the Caribbean: A review
33. Toxocara prevalence in dogs and cats in Brazil
34. Prevalence of Toxocara spp. in dogs and cats in South America (excluding Brazil)
35. Prevalence of patent Toxocara spp. infections in dogs and cats in Europe from 1994 to 2019
36. Toxocara prevalence in dogs, cats and the environment in Russia
37. Canine Toxocariosis: Its prevalence, incidence and occurrence in the Indian subcontinent
38. Epidemiology of Toxocara spp. in dogs and cats in mainland China, 2000–2019
39. Prevalence of Toxocara in dogs and cats in Africa
40. Toxocara canis in Australia
41. Toxocariasis: A neglected infection for the Anthropocene epoch
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 109
- Published: April 30, 2020
- Language: English
About the editor
About the editor
DB
Dwight D. Bowman
Dr. Bowman is a Professor in the Department of Microbiology and Immunology, Cornell University, NY, and has been associated with the department since 1987 (previously an assistant professor,1987-1993). He received the MS degree in Parasitology from Tulane University in 1976. He then received his PhD from Tulane University in 1983 studying Parasitology. He has held successive positions at Cornell University since 1987. He has obtained continuous funding (corporate and federal) throughout his career to study animal parasitology.
Affiliations and expertise
Associate Professor of Parasitology, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USAView book on ScienceDirect
View book on ScienceDirect
Read Toxocara and Toxocariasis on ScienceDirect